These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 20514525)

  • 21. In vitro changes in plasma membrane heparan sulfate proteoglycans and in perlecan expression participate in the regulation of fibroblast growth factor 2 mitogenic activity.
    Guillonneau X; Tassin J; Berrou E; Bryckaert M; Courtois Y; Mascarelli F
    J Cell Physiol; 1996 Jan; 166(1):170-87. PubMed ID: 8557766
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Suppression of autocrine and paracrine functions of basic fibroblast growth factor by stable expression of perlecan antisense cDNA.
    Aviezer D; Iozzo RV; Noonan DM; Yayon A
    Mol Cell Biol; 1997 Apr; 17(4):1938-46. PubMed ID: 9121441
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparative immunolocalisation of perlecan, heparan sulphate, fibroblast growth factor-18, and fibroblast growth factor receptor-3 and their prospective roles in chondrogenic and osteogenic development of the human foetal spine.
    Shu C; Smith SS; Little CB; Melrose J
    Eur Spine J; 2013 Aug; 22(8):1774-84. PubMed ID: 23397188
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cell surface heparan sulfate proteoglycans control the response of renal interstitial fibroblasts to fibroblast growth factor-2.
    Clayton A; Thomas J; Thomas GJ; Davies M; Steadman R
    Kidney Int; 2001 Jun; 59(6):2084-94. PubMed ID: 11380810
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Impaired angiogenesis, delayed wound healing and retarded tumor growth in perlecan heparan sulfate-deficient mice.
    Zhou Z; Wang J; Cao R; Morita H; Soininen R; Chan KM; Liu B; Cao Y; Tryggvason K
    Cancer Res; 2004 Jul; 64(14):4699-702. PubMed ID: 15256433
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Syndecan-3 and perlecan are differentially expressed by progenitors and mature oligodendrocytes and accumulate in the extracellular matrix.
    Winkler S; Stahl RC; Carey DJ; Bansal R
    J Neurosci Res; 2002 Aug; 69(4):477-87. PubMed ID: 12210841
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The niche factor syndecan-1 regulates the maintenance and proliferation of neural progenitor cells during mammalian cortical development.
    Wang Q; Yang L; Alexander C; Temple S
    PLoS One; 2012; 7(8):e42883. PubMed ID: 22936997
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Removal of heparan sulfate by heparinase treatment inhibits FGF-2-dependent smooth muscle cell proliferation in injured rat carotid arteries.
    Kinsella MG; Irvin C; Reidy MA; Wight TN
    Atherosclerosis; 2004 Jul; 175(1):51-7. PubMed ID: 15186946
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Histamine up-regulates fibroblast growth factor receptor 1 and increases FOXP2 neurons in cultured neural precursors by histamine type 1 receptor activation: conceivable role of histamine in neurogenesis during cortical development in vivo.
    Molina-Hernández A; Rodríguez-Martínez G; Escobedo-Ávila I; Velasco I
    Neural Dev; 2013 Mar; 8():4. PubMed ID: 23497494
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Characterization of proteoglycans synthesized by murine embryonal carcinoma cells (P19) reveals increased expression of perlecan (heparan sulfate proteoglycan) during neuronal differentiation.
    Sekiguchi RT; Potter-Perigo S; Braun K; Miller J; Ngo C; Fukuchi K; Wight TN; Kimata K; Snow AD
    J Neurosci Res; 1994 Aug; 38(6):670-86. PubMed ID: 7807583
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Heparan sulfate alterations in extracellular matrix structures and fibroblast growth factor-2 signaling impairment in the aged neurogenic niche.
    Yamada T; Kerever A; Yoshimura Y; Suzuki Y; Nonaka R; Higashi K; Toida T; Mercier F; Arikawa-Hirasawa E
    J Neurochem; 2017 Aug; 142(4):534-544. PubMed ID: 28547849
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Not all perlecans are created equal: interactions with fibroblast growth factor (FGF) 2 and FGF receptors.
    Knox S; Merry C; Stringer S; Melrose J; Whitelock J
    J Biol Chem; 2002 Apr; 277(17):14657-65. PubMed ID: 11847221
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Increased intimal hyperplasia and smooth muscle cell proliferation in transgenic mice with heparan sulfate-deficient perlecan.
    Tran PK; Tran-Lundmark K; Soininen R; Tryggvason K; Thyberg J; Hedin U
    Circ Res; 2004 Mar; 94(4):550-8. PubMed ID: 14739157
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A gradient of matrix-bound FGF-2 and perlecan is available to lens epithelial cells.
    Wu W; Tholozan FM; Goldberg MW; Bowen L; Wu J; Quinlan RA
    Exp Eye Res; 2014 Mar; 120(100):10-4. PubMed ID: 24341990
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A subset of fibroblast growth factors (Fgfs) promote survival, but Fgf-8b specifically promotes astroglial differentiation of rat cortical precursor cells.
    Hajihosseini MK; Dickson C
    Mol Cell Neurosci; 1999 Dec; 14(6):468-85. PubMed ID: 10656254
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Drosophila perlecan modulates FGF and hedgehog signals to activate neural stem cell division.
    Park Y; Rangel C; Reynolds MM; Caldwell MC; Johns M; Nayak M; Welsh CJ; McDermott S; Datta S
    Dev Biol; 2003 Jan; 253(2):247-57. PubMed ID: 12645928
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Antisense targeting of perlecan blocks tumor growth and angiogenesis in vivo.
    Sharma B; Handler M; Eichstetter I; Whitelock JM; Nugent MA; Iozzo RV
    J Clin Invest; 1998 Oct; 102(8):1599-608. PubMed ID: 9788974
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Essential contribution of tumor-derived perlecan to epidermal tumor growth and angiogenesis.
    Jiang X; Multhaupt H; Chan E; Schaefer L; Schaefer RM; Couchman JR
    J Histochem Cytochem; 2004 Dec; 52(12):1575-90. PubMed ID: 15557212
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Electrophoretic, biosensor, and bioactivity analyses of perlecans of different cellular origins.
    Knox S; Melrose J; Whitelock J
    Proteomics; 2001 Dec; 1(12):1534-41. PubMed ID: 11747213
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Diverse FGF receptor signaling controls astrocyte specification and proliferation.
    Kang K; Song MR
    Biochem Biophys Res Commun; 2010 May; 395(3):324-9. PubMed ID: 20362555
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.